N-(4-chlorobenzyl)butyramide | 571164-79-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-chlorobenzyl)butyramide
• 英文别名: N-(4-chlorobenzyl)butanamide；N-[(4-chlorophenyl)methyl]butanamide
• CAS: 571164-79-9
• 化学式: C₁₁H₁₄ClNO
• mdl: MFCD00757370
• 分子量: 211.691
• InChiKey: AOLOVPRVWXNVRZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  丁酸甲酯 、 对氯苄胺 在 calcium iodide 作用下， 以 甲苯 为溶剂， 反应 4.0h， 以78%的产率得到N-(4-chlorobenzyl)butyramide
  参考文献：
  名称：

  Chemoselective calcium-catalysed direct amidation of carboxylic esters

  摘要：

  廉价、无毒且对环境友好的CaI₂催化剂可在优异收率下直接催化未活化的羧酸酯与一级胺之间的酰胺键形成。

  DOI：

  10.1039/c5ra18288c

文献信息

• Transamidation of primary amides with amines catalyzed by zirconocene dichloride
  作者：Benjamin N. Atkinson、A. Rosie Chhatwal、Helen V. Lomax、James W. Walton、Jonathan M. J. Williams

  DOI：10.1039/c2cc37427g

  日期：——

  Zirconocene dichloride (Cp(2)ZrCl(2)) has been shown to be an effective catalyst for the transamidation of primary amides with amines in cyclohexane at 80 degrees C in 5-24 hours. For favourable substrates, the reaction can be performed at temperatures as low as 30 degrees C.

  二氯化锆（Cp（2）ZrCl（2））已显示是在环己烷中于80摄氏度下于5-24小时内将伯酰胺与胺进行氨基转移的有效催化剂。对于有利的底物，反应可以在低至30摄氏度的温度下进行。
• Transamidation of Primary Amides with Amines Using Hydroxylamine Hydrochloride as an Inorganic Catalyst
  作者：C. Liana Allen、Benjamin N. Atkinson、Jonathan M. J. Williams

  DOI：10.1002/anie.201107348

  日期：2012.2.6

  Metal‐free catalysis: A method for the transamidation of primary amides with primary or secondary amines provides access to secondary and tertiary amides, by utilizing catalytic quantities of hydroxylamine hydrochloride to activate the chemically robust primary amide group (see scheme). A mechanism of primary amide activation through a hydrogen‐bonding complex is proposed.

  无金属催化：一种伯胺与伯胺或仲胺进行氨基转移的方法，可利用催化量的盐酸羟胺活化化学上强健的伯酰胺基团（参见方案），从而获得仲酰胺和叔酰胺。提出了通过氢键络合物活化伯酰胺的机理。
• beta-sheet mimetics and composition and methods relating thereto
  申请人：Myriad Pharmaceuticals, Inc.

  公开号：US20040014763A1

  公开（公告）日：2004-01-22

  Compounds having the following structure: 1 including pharmaceutically acceptable salts and stereoisomers thereof, wherein A, A′, B, X, Y, R 2 , R 3 , R 4 and R 5 are as defined herein. Such compounds have utility over a wide range of applications, including use as diagnostic and therapeutic agents. In particular, compounds of this invention, and pharmaceutical compositions containing such compounds, are tryptase antagonists.

  具有以下结构的化合物：1，包括药用可接受的盐及其立体异构体，其中A、A'、B、X、Y、R2、R3、R4和R5如本文所定义。这些化合物在广泛的应用范围内具有实用性，包括用作诊断和治疗剂。特别是，本发明的化合物和含有这些化合物的药物组合物是色胺酸蛋白酶抑制剂。
• Catalytic Acylation of Amines with Aldehydes or Aldoximes
  作者：C. Liana Allen、Simge Davulcu、Jonathan M. J. Williams

  DOI：10.1021/ol101978h

  日期：2010.11.19

  The simple nickel salt NiCl2 center dot 6H(2)O catalyzes the coupling of aldoximes with amines to give secondary or tertiary amide products. The aldoxime can be prepared in situ from the corresponding aldehyde. The use of O-18-labeled oximes has allowed insight into the mechanism of this reaction.
• MODULATORS OF THE INTEGRATED STRESS PATHWAY
  申请人：Calico Life Sciences LLC

  公开号：EP3452453B1

  公开（公告）日：2022-04-13